Charles River Laboratories Endosafe Trillium

Rapid test 2019-nCoV Total Immunoglobulins (V1210/V1230)

Rapid Test 2019 nCoV

Principle: Lateral flow method

Automation: No

Approvals: Currently Under approval by FDA, Pending CE IVD mark

Suitability: Medical teams, countries’ entry points, suitable for field use

Capital equipment required: No


Rapid test 2019-nCoV Total is a qualitative Lateral Flow test for the determination of IgA, IgM, and IgG antibodies against SARS-CoV-2 in human serum, plasma, or whole blood specimens.

Key Points:
  • Lateral flow in dip stick format available in 10 or 30 test sticks
  • Clinical Diagnostic Sensitivity (98.75%) and Clinical Diagnostic Specificity (100%)
  • Low procedure time: 10 min
  • Easy-to-use method, no need for equipment or special facilities
  • Visual interpretation of the results
  • Shelf Life: 12 months | Storage 4-30°C


Company contact details:

ProGnosis Biotech S.A view full details

Website: Visit Website
Tel: + 30-2410623922

safe and easy sterility testing patented dual needle unique sterisart septum watch video

Data Integrity as an Indicator of Quality Control Issues

BioMerieux at PDA 2023

Condalab Brochure Download

Charles River Webinar Recombinant Cascade Reagent

Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!